Aspartame and Seizures

Overview

Journal Amino Acids

Specialty Biochemistry

Date 2013 Nov 6

PMID 24190604

Authors

P C Jobe

J W Dailey

Affiliations

Soon will be listed here.

Abstract

It has been hypothesized that the dietary sweetener aspartame (L-aspartyl-L-phenylalanine methyl ester) might promote seizures and this hypothesis has been argued in the published literature. The current manuscript reviews the biochemical, neurochemical and behavioral experiments that have been carried out in order to assess the hypothesis linking aspartame with seizure promotion. We conclude that convulsive seizures are not caused by orally administered aspartame in rodents or in primates, including humans. Early reports of seizure facilitation by aspartame in several rodent models were not confirmed by later and more careful experimentation. Proconvulsive effects were absent in humans and other mammals with epilepsy and those without epilepsy. Lack of convulsive liability was evident, even when doses many fold higher than those consumed in the human diet, were used in experimental paradigms. Studies of aspartame in absence seizures are not as complete as those in convulsive seizures, but available evidence in humans does not document an association between absence seizure incidence and aspartame usage.

References

Fernstrom J . Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev. 1983; 63(2):484-546. DOI: 10.1152/physrev.1983.63.2.484. View

Hjelle J, Dudley R, Marietta M, Sanders P, Dickie B, Brisson J . Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame. Pharmacology. 1992; 44(1):48-60. DOI: 10.1159/000138873. View

Porta M . The search for more clinically meaningful research designs: single-patient randomized clinical trials. J Gen Intern Med. 1986; 1(6):418-9. DOI: 10.1007/BF02596430. View

Dailey J, Lasley S, Mishra P, Bettendorf A, Burger R, Jobe P . Aspartame fails to facilitate pentylenetetrazol-induced convulsions in CD-1 mice. Toxicol Appl Pharmacol. 1989; 98(3):475-86. DOI: 10.1016/0041-008x(89)90176-2. View

Cain D, Boon F, Bevan M . Failure of aspartame to affect seizure susceptibility in kindled rats. Neuropharmacology. 1989; 28(4):433-5. DOI: 10.1016/0028-3908(89)90042-7. View

Fernstrom J, Fernstrom M, Gillis M . Acute effects of aspartame on large neutral amino acids and monoamines in rat brain. Life Sci. 1983; 32(14):1651-8. DOI: 10.1016/0024-3205(83)90873-1. View

Butchko H, Kotsonis F . Acceptable daily intake vs actual intake: the aspartame example. J Am Coll Nutr. 1991; 10(3):258-66. DOI: 10.1080/07315724.1991.10718153. View

Jobe P, Lasley S, Burger R, Bettendorf A, Mishra P, Dailey J . Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats. Amino Acids. 2013; 3(2):155-72. DOI: 10.1007/BF00806781. View

McLeod R, Taylor D, Cohen Z, Cullen J . Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet. 1986; 1(8483):726-8. DOI: 10.1016/s0140-6736(86)91112-8. View

10.

Loscher W, Nolting B, Fassbender C . The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles. Epilepsy Res. 1990; 7(3):173-81. DOI: 10.1016/0920-1211(90)90013-l. View

11.

Guiso G, Caccia S, Vezzani A, Stasi M, Salmona M, Romano M . Effect of aspartame on seizures in various models of experimental epilepsy. Toxicol Appl Pharmacol. 1988; 96(3):485-93. DOI: 10.1016/0041-008x(88)90008-7. View

12.

Stegink L, REYNOLDS W, FILER Jr L, Pitkin R, Boaz D, Brummel M . Monosodium glutamate metabolism in the neonatal monkey. Am J Physiol. 1975; 229(1):246-50. DOI: 10.1152/ajplegacy.1975.229.1.246. View

13.

Giroud M, Dumas R, DAUVERGNE M, dAthis P, Rochette L, Beley A . 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of children with febrile convulsions. Epilepsia. 1990; 31(2):178-81. DOI: 10.1111/j.1528-1167.1990.tb06303.x. View

14.

REYNOLDS W, FILER Jr L, Pitkin R . Monosodium glutamate: absence of hypothalamic lesions after ingestion by newborn primates. Science. 1971; 172(3990):1342-4. DOI: 10.1126/science.172.3990.1342. View

15.

Walton R . Seizure and mania after high intake of aspartame. Psychosomatics. 1986; 27(3):218, 220. DOI: 10.1016/S0033-3182(86)72715-1. View

16.

Jobe P, PICCHIONI A, Chin L . Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat. Life Sci. 1973; 13(1):1-13. View

17.

McNamara J, Byrne M, Dasheiff R, Fitz J . The kindling model of epilepsy: a review. Prog Neurobiol. 1980; 15(2):139-59. DOI: 10.1016/0301-0082(80)90006-4. View

18.

Zhi J, Levy G . Aspartame and phenylalanine do not enhance theophylline-induced seizures in rats. Res Commun Chem Pathol Pharmacol. 1989; 66(1):171-4. View

19.

Guyatt G, Sackett D, Taylor D, Chong J, Roberts R, Pugsley S . Determining optimal therapy--randomized trials in individual patients. N Engl J Med. 1986; 314(14):889-92. DOI: 10.1056/NEJM198604033141406. View

20.

NEAME K . A comparison of the transport systems for amino acids in brain, intestine, kidney and tumour. Prog Brain Res. 1968; 29:185-99. DOI: 10.1016/S0079-6123(08)64156-4. View